Sec. 4. Medicare coverage of home infusion drugs

140 words·~1 min read·/bill/113/hr/5435/ih/section-4

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Section 1860D–2(e) of the Social Security Act ( 42 U.S.C. 1395w–102(e) ) is amended— in paragraph (1)— by striking or at the end of subparagraph (A); by striking the comma at the end of subparagraph

(B)and inserting, ; or ; and by inserting after subparagraph

(B)the following new subparagraph: an infusion drug (as defined in paragraph (5)), ; and by adding at the end the following new paragraph: For purposes of this part, the term infusion drug means a parenteral drug or biological administered via an intravenous, intraspinal, intra-arterial, intrathecal, epidural, subcutaneous, or intramuscular access device or injection, and may include a drug used for catheter maintenance and declotting, a drug contained in a device, additives including but not limited to vitamins, minerals, solutions, and diluents, and other components used in the provision of home infusion therapy. .

Connections1 off-index

1 reference not yet in our index

42 USC 1395w–102(e)

Citation graph

cites case law

Sec. 4

Medicare coverage of home infusion drugs

Cite42 USC 1395w–102(e)

Cites 1Cited by 0 across 0 sources